3-D replica informs an innovative operation in a deeply cyanosed child
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/1866cb5b-495e-48a1-81a0-fa9a9b25949e/HVI-1572623_04-29-19_018_MLC-jpg)
3D heart
By Patcharapong Suntharos, MD, and Hani Najm, MD
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Ethan is a 9-year-old boy with heterotaxy syndrome that was characterized by complex congenital heart disease involving the following:
As an infant, he underwent TAPVR repair with anastomosis of the pulmonary venous confluence to the right side of the common atrium followed by unifocalization of his MAPCAs to a 12-mm aortic homograft-valved conduit connected to the right ventricle. He later underwent nine cardiac catheterizations, mainly to alleviate significant pulmonary artery branch stenoses and augment pulmonary artery blood flow. Nevertheless, he still had profound cyanosis.
In July 2016, we needed to innovate a procedure to improve oxygen saturation values in this deeply cyanosed child, but standard imaging modalities were inadequate for surgical planning. Building on Cleveland Clinic’s experience developing 3-D-printed heart replicas to plan transcatheter pulmonary valve implantations in patients with congenital defects, we decided to generate a 3-D-printed model of Ethan’s heart to assist our planning.
Using contrast-enhanced MRIs and CTs of his heart, we developed the 3-D-printed model shown above, which allowed us to examine the probability of whether a procedure could improve his oxygen saturations. When the surgeon (co-author Hani Najm, MD) was able to hold the exquisitely detailed heart replica in hand and make an incision in it, the feasibility of our proposed novel procedure was demonstrated.
Advertisement
That procedure was executed in real life exactly as planned on the 3-D replica, and the outcome was excellent. Ethan is now doing very well, with saturation percentages in the low 90s — a level he had never achieved before.
3-D-printed heart replicas are exceptional tools for planning percutaneous and surgical interventions for complex congenital heart defects. Our team looks forward to more opportunities to apply this technology in previously untreatable cases.
Dr. Suntharos is a pediatric and congenital interventional cardiologist, and Dr. Najm is Chair of Pediatric and Congenital Heart Surgery, both at Cleveland Clinic.
Advertisement
Advertisement
Elevated levels of the gut microbial metabolite predict prevalence and adverse outcomes in community-based study
They generally depend on the mutated gene, clone size and clinical setting
Large analysis adds to evidence that absolute diameter alone may miss vulnerable patients
Procedure places the center among only a handful worldwide to offer the minimally invasive approach
Phase 1 trial shows up to 97% decrease through 48 weeks with good tolerability
Post hoc ALPACA analysis boosts biological rationale for ongoing outcomes trial of lepodisiran
Durability findings propel potential one-time treatment approach to phase 1b testing
Practical takeaways for the reality of overlapping cardiovascular, kidney and metabolic disease